BioSpace News Archive

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the initiation of an open-label extension study.

Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced promising preclinical data for multiple compounds in its lead program for Parkinson’s disease, during an oral presentation at the Michael J. Fox Foundation’s 14th annual Parkinson’s Disease Therapeutics Conference.

ACLIV, a Korean biotech company has obtained EPA approval. Its EPA registration number is 102332.

FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced appointment of two experienced medical device experts to support the company’s next clinical and industrial phases.

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or the “Company”) is pleased to announce that it has closed the first tranche (the “First Tranche”) of its non-brokered private placement of convertible notes (the “Notes”) previously announced on April 7, 2022 and October 7, 2022.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced today that it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC (“Nasdaq”) on October 12, 2022 informing Kiora that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.

According to Nova one advisor, the The global Digital Therapeutics market gathered revenue around USD 3.9 Billion in 2020 and market is set to grow USD 20.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 24.0% during the prediction period 2021 to 2027.

According to Nova one advisor, the the global Medical Information market gathered revenue around USD 4.1 Billion in 2020 and market is set to grow USD 6.4 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 9.1% during the prediction period 2021 to 2027.

According to Nova one advisor, the global Oncology Information Systems market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 4.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.0% during the prediction period 2022 to 2030.

F2G Ltd today announced that it will present new clinical data in three oral presentations and two poster presentations at IDWeek 2022, to be held in Washington, D.C. from October 19-23, 2022.